Skip to main content
. 2026 Jun 9;15(6):729. doi: 10.3390/antiox15060729
DAG diacylglycerol
DHA docosahexaenoic acid
EPA eicosapentaenoic acid
FASN fatty acid synthase
GLP1-RA glucagon-like peptide-1 receptor agonist
GSH reduced form of glutathione
GSSG oxidized form of glutathione
HMGCR 3-hydroxy-3-methylglutaryl-coenzyme A reductase
HOMA-IR Homeostatic Model Assessment for Insulin Resistance
4-HNE 4-hydroxynonenale
IL-6 interleukin 6
MDA malondialdehyde
MASLD metabolic dysfunction-associated steatotic liver disease
MCP-1 monocyte chemoattractant protein-1
NAFLD non-alcoholic fatty liver disease
NEFA non-esterified fatty acid
NRF2 nuclear factor erythroid-2-related factor 2
OVX ovariectomized females
PPARα peroxisome proliferator-activated receptor alpha
PPARγ peroxisome proliferator-activated receptor gamma
SCD1 stearoyl-coenzyme A desaturase 1
SREBP1 sterol regulatory element-binding protein 1
TAG triacylglycerol
TGFβ transforming growth factor beta
TNFα tumor necrosis factor alpha